Health & Fitness

According to FutureWise analysis the market for anti-venom in 2023 was US$ 0.65 billion, and is expected to reach US$ 1.32 billion by 2031 at a CAGR of 9.1%. Anti-venom, also referred to as antivenin, is a therapeutic treatment designed to counteract the effects of venom from specific animals when administered promptly after a snakebite or other venomous encounter. This treatment relies on purified antibodies that specifically target the components of venom. These antibodies are produced from animals that have been exposed to the venom through a controlled process. The method of extracting venom differs based on the species. For instance, snakes and funnel-web spiders are usually milked to collect their venom using a specific technique. In contrast, venom from stonefish, redback spiders, and box jellyfish is often obtained through dissection, which can be a risky procedure. Immune animals are injected with small amounts of venom, with the dosage gradually increased as the animals ... Continue reading →

According to FutureWise analysis the market for antiarrhythmic drugs in 2023 was US$ 1.16 billion, and is expected to reach US$ 1.81 billion by 2031 at a CAGR of 5.7%. Antiarrhythmic drugs are essential medications designed to treat and prevent abnormal heart rhythms, known as arrhythmias, which arise due to disruptions in the heart's electrical system. These arrhythmias may present as excessively fast, slow, or irregular heartbeats. Antiarrhythmic agents are effective in managing conditions such as atrial flutter, atrial fibrillation, and ventricular fibrillation. These medications are categorized using the Vaughan-Williams classification system, which organizes them based on their primary mechanisms of action. However, it's important to note that many drugs may exhibit properties from multiple classes. Administration of antiarrhythmic medications can occur either intravenously or orally, depending on the severity of the condition. For instance, class I antiarrhythmics such ... Continue reading →

Air Ambulance Services from Kolkata has a long running history of offering the best repatriation service to the patients as it is designed to meet the necessities of the patients, ensuring the journey isn’t risky or complicated at any point. With the help of our team at Panchmukhi, air medical transport is organized in the safest possible manner, allowing the evacuation mission to be conducted without causing trouble at any point. We have been doing our very best to offer services in favor of the patients, enabling end-to-end care and comfort at every step. Air Ambulance Services in Kolkata has a 24/7 worldwide availability offering repatriation via our medically fitted fleet of jets that are tailored to meet the urgent requirements of the patients during critical emergencies. Availability of critical care team, best-in-line equipment, and advanced facilities can contribute to making your flying experience smooth and trouble-free during an emergency, allowing the journey to be ... Continue reading →

When the patient is in critical need of advanced treatment and hiring an air medical transport isn’t easy, one must trust transportation of patients via train, which is available at a relatively lower cost. Medivic has been the best source of medical transport, organizing Train Ambulance in Patna for the convenience of the patients, ensuring the journey is favorable to the needs of the patients, and helpful in shifting them over longer distances in the best possible manner. The convenience of the patients is always kept at the top while composing our repatriation mission, and we manage to deliver the best solution that can end up being in their favor. We utilize our best practices, enabling the transportation of critical patients without complications, and ensure the sets are booked only in AC compartments. At Train Ambulance Service in Patna, we choose AC 1st, 2nd, or 3rd tier compartments for the booking and shift patients easily to the opted location. Relocation of Critical ... Continue reading →

Creative Diagnostics, a global provider of reagents and analytical services, has released its innovative Gene Copy Number Assay Kits designed to accurately quantify the number of specific genes present in biological samples. These kits utilize quantitative PCR (qPCR) technology to provide precise and sensitive measurements of gene copy numbers, helping to accelerate research in genetics, molecular biology, and diagnostics. These assays support a wide range of applications, by detecting and quantifying gene copies with high specificity. These applications include gene expression studies, disease research, and genetic testing. Thus, this provides a powerful contribution to the development of these studies. By providing a way to directly measure gene copy numbers, these kits can help researchers analyze genetic variations in a more efficient way and better understand gene function. These advantages are due to the rapid turnaround time and reliable results of these Gene Copy ... Continue reading →

STEMart, a US-based provider of comprehensive services for all phases of medical device development, recently announced its the launch of its comprehensive Flow Cytometry Services to meet the diverse needs of research, diagnostics, and clinical studies, offering scientists and clinicians access to powerful tools for detailed cellular analysis, including cellular functions, phenotypes, and molecular interactions. Flow cytometry is a technique for rapid multiparameter analysis of single cells in solution. It uses a laser as a light source to produce scattered light and fluorescence signals that are read by a detector such as a photodiode or photomultiplier tube. These signals are converted into electronic signals that are analyzed by a computer and written to a standard format (.fcs) data file. Cell populations can be analyzed and purified based on their fluorescence or light scattering characteristics. A variety of fluorescent reagents are utilized in flow cytometry. These ... Continue reading →

Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models. Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART™ technology platform, Protheragen provides investigators a wide range of disease models to ensure detailed and customized treatment methods for superior therapeutic outcomes. With the development of immunology, scientists have come to recognize the potential of the immune system in recognizing and attacking cancer cells, especially the key role of T cells in anti-tumor immunity. Protheragen leverages this property of T cells to study and develop a variety of disease models to evaluate the effectiveness of immunotherapy and ensure optimal therapeutic outcomes through its innovative EndureCART™ technology. In the field of tumor therapy, the emergence of CAR-T cell therapy provides ... Continue reading →

A wide range of cost-effective animal models, from Drosophila to non-human primates, from knockout models to different disease models, are released. In a pioneering effort to revolutionize life science research, a wide range of cost-effective animal disease models, from Drosophila to non-human primates, from knockout models to different disease models, are released. These groundbreaking models are set to empower researchers worldwide by enabling them to unravel the mysteries of various diseases more efficiently and affordably than ever before. Animal models can provide valuable information about various diseases and can be used to study disease progression, develop new treatments, and test the efficacy of experimental drugs. However, the exorbitant costs associated with traditional animal models have proven to be a substantial barrier for many researchers. Addressing this challenge head-on, cost-effective animal disease models have been developed as an innovative solution that ... Continue reading →

According to FutureWise analysis the market for Antibiotic Resistance in 2023 was US$ 8.61 million, and is expected to register a CAGR of 5.90% in 2023-2031 Antibiotics are essential medications used for the prevention and treatment of bacterial infections. However, a growing concern in healthcare is antimicrobial resistance, which occurs when microorganisms, including bacteria and fungi, develop the ability to resist the effects of the drugs intended to eliminate them. This resistance is exacerbated by the misuse and overuse of antibiotics, as well as inadequate infection prevention and management practices. Infections caused by resistant microbes can often be challenging, and sometimes even impossible, to treat effectively. Antibiotic resistance is a natural phenomenon; nevertheless, the increase in resistance cases is largely influenced by the exposure of microorganisms to antibiotics and antifungals. This exposure allows resistant strains to proliferate and can lead to their ... Continue reading →

According to FutureWise analysis the market for antibodies in 2023 was US$ 0.83 billion, and is expected to reach US$ 2.32 billion by 2031 at a CAGR of 13.6%. Antibodies, also referred to as immunoglobulins, are specialized proteins that are synthesized by plasma cells within the immune system in response to specific antigens. These antigens can be pathogens, such as viruses and bacteria, or other foreign substances that the body recognizes as threats. Antibodies play a crucial role in the immune response by binding to these antigens, marking them for destruction by other immune cells, or neutralizing their harmful effects. The therapeutic and diagnostic applications of antibodies are vast and continuously expanding. They are employed in the treatment and management of various diseases, including autoimmune disorders such as rheumatoid arthritis, hematological malignancies like non-Hodgkin lymphoma, and inflammatory conditions such as psoriasis and Crohn’s disease. Antibodies ... Continue reading →